Based in Boca Raton, Fla., Xeriant acquires, develops and commercializes disruptive technologies, with a focus on eco-friendly advanced materials and next-generation aircraft. For the year ended June 30, Xeriant reported a net loss of $16M with no revenue.
Xeriant has a joint venture with Slovakian chemical company Movychem for the commercialization of Movychem's Retacell flame retardation technology. It has a second joint venture with XTI Aircraft for development of a six-seater eVTOL fixed-wing aircraft called the TriFan 600.
Other publicly traded eVTOL developers include Joby (JOBY), Eve (EVEX), Vertical Aerospace (EVTL), Archer Aviation (ACHR) and Lilium (LILM).